Incyte (NASDAQ:INCY) Price Target Increased to $77.00 by Analysts at Stifel Nicolaus

Incyte (NASDAQ:INCY – Get Rating) had its price objective raised by Stifel Nicolaus from $75.00 to $77.00 in a research note published on Tuesday, The Fly reports. Several other analysts have also issued reports on INCY. StockNews.com started coverage on shares of Incyte in a research report on Thursday, March 31st. They set a strong-buy […]

Related Keywords

Zurich ,Züsz ,Switzerland ,United States ,Canada ,Kentucky ,Thomson Reuter ,Stifel Nicolaus ,Morgan Stanley ,Kentucky Retirement Systems Insurance Trust Fund ,Zacks Investment Research ,Indexiq Advisors ,National Asset Management Inc ,Nasdaq ,Bank Julius Baer Co ,Ltd Zurich ,Ieq Capital ,Incyte Corporation ,Royal Bank ,Get Rating ,Advisors Lp Baker ,Julius Baer ,Asset Management ,Retirement Systems Insurance Trust Fund ,Incyte ,Nasdaq Incy ,Incy ,Medical ,45337c10 ,Boost Price Target ,